Nektar Therapeutics
Oligomer-opioid agonist conjugates
Last updated:
Abstract:
The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
Status:
Grant
Type:
Utility
Filling date:
19 Oct 2018
Issue date:
24 Dec 2019